Document is current
Any future updates will be listed below
-
Authors
Trolle, Julie https://orcid.org/0000-0002-2497-3531
Sessa, Sofia
Wudzinska, Aleksandra
Grivainis, Mark https://orcid.org/0000-0001-8156-7153
Rincones, Katerina
Rodrick, Tori https://orcid.org/0009-0006-6201-6579
Jones, Drew R.
Fenyö, David https://orcid.org/0000-0001-5049-3825
Pinglay, Sudarshan https://orcid.org/0000-0002-8781-1476
Boeke, Jef D. https://orcid.org/0000-0001-5322-4946
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute (RM1-HG009491)
The SeaBridge Fellowship is funded by the Washington Research Foundation, Brotman Baty Institute, and the Chan Zuckerberg Initiative.
U.S. Department of Health & Human Services | NIH | NIH Office of the Director (DP5OD036167)
- License Information
-
More Information
Article History
Received: 8 July 2025
Accepted: 20 August 2026
First Online: 6 October 2026
Ethics
Competing interests: Two patent applications related to this work have been filed with J.T., S.P. and J.D.B. listed as inventors on one or both applications (US Patent application nos. 63/533,483 and 63/828,744). J.D.B. is a founder and director of CDI Labs, a founder of and consultant to Opentrons LabWorks/Neochromosome and a founder of JATech and serves or served on the scientific advisory boards of CZ Biohub New York, Logomix, Rome Therapeutics, SeaHub, Tessera Therapeutics and the Wyss Institute.
